Cynthia L. Verst,
PharmD
Director DIA
President, R&D Design and Delivery Innovation, IQVIA
Dr. Cynthia L. Verst, President of Design and Delivery Innovation for Research and Development Solutions at IQVIA, is responsible for accelerating growth through innovative solutions powered by rich data assets, advanced predictive analytics, integrated technology capabilities, and deep domain expertise to develop actionable insights for IQVIA clients and to drive better clinical research outcomes.
Dr. Verst has a proven track record of operational excellence and innovation amidst an increasingly complex healthcare environment. Before being appointed as President, Dr. Verst served as President of Clinical Operations; prior to that, she served as President of Real-World & Late Phase Research at Quintiles. Her other executive leadership positions include serving at OptumInsight (a division of United Healthcare) and at Procter & Gamble Pharmaceuticals as Section Head in its North American Medical and Technical Affairs group, where she successfully led the phase 3b/4 research requirements of marketed products. In 2014, Dr. Verst was named one of the top women in biotech by FierceBiotech, an annual award that spotlights an elite list of 15 women leaders in the life sciences, academia, and regulatory roles. She also serves as the 2018 Vice Chairman of the Association of Clinical Research Organizations. Dr. Verst earned her PharmD and Bachelor of Pharmacy degree from the University of Cincinnati, her MS in Structural and Cellular Biology from the University of Illinois, and Bachelor’s degrees in Biology and Chemistry from Northern Kentucky University.
Our Leadership
-
PharmD •Chair DIA
Senior Advisor R&D
Bayer AG -
MBA •Immediate Past Chair DIA
President and Chief Executive Officer
Cancer Genetics, Inc. (CGI) -
RPh •Chair-Elect DIA
Head, Product Development Medical Affairs Customer Strategy
F. Hoffmann-La Roche Ltd. -
CPA, CGMA •Secretary/Treasurer DIA
Chief Financial Officer
Katabat -
MS • Global Chief Executive
DIA
-
MD, PhD, DSc •Director DIA
Director, Deputy Qualified Person for Pharmacovigilance, Global Patient Safety
Eli Lilly and Company, Ltd. -
MPharm •Director DIA
Executive Director, Global Regulatory Policy
Merck Sharp & Dohme (Europe) Inc. -
MD •Director DIA
Chief Scientific Officer
Syneos Health -
CPA •Director DIA
Partner, Life Science Industry Practice Group, RSM US -
MD •Director DIA
Chief Medical Officer
Flagship Pioneering -
PhD •Director DIA
Senior Vice President
QIAGEN -
MD, PhD •Director DIA
Vice President and Senior Managing Director, Development & Medical Affairs, GlaxoSmithKline Japan -
PhD •Director DIA
Chairman and Chief Executive Officer
dMed Company Limited -
PharmD •Director DIA
President, R&D Design and Delivery Innovation, IQVIA
-
PharmD • Chair, Executive Committee
-
CPA • Member, Executive Committee -
MBA • Member, Executive Committee -
RPh • Member, Executive Committee -
MS • Member, Executive Committee
-
CPA • Chair, Audit Committee -
MD, PhD, DSc • Member, Audit Committee -
MPharm • Member, Audit Committee -
PharmD • Member, Audit Committee -
PharmD • Member, Audit Committee
-
PhD • Chair, Council of Regulators
Leadership Committee
Japan Pharmaceuticals and Medical Devices Agency Liaison to the DIA Board -
PhD • Council of Regulators
Leadership Committee
European Medicines Agency Liaison to the DIA Board -
MD • Council of Regulators
Leadership Committee
US Food and Drug Administration Liaison to the DIA Board -
PhD • Council of Regulators
Swissmedic Liaison to the DIA Board
-
MS • Global Chief Executive -
MS, CPA • Chief Financial Officer -
-
DIA EMEA -
PhD • Senior Vice President & Managing Director
DIA South Korea and ASEAN -
PhD • Senior Vice President & Managing Director
DIA Americas -
PhD • Senior Vice President & Managing Director
DIA Japan -
RPh, MBA • Senior Vice President & Managing Director
DIA Greater China